mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000

View company profile
Current Jobs

NHS Customer Insight Manager
Location: Guildford

Partnership Development Manager
Location: UK

Sanofi-aventis announces collaboration with Regeneron

Posted on 16/11/2009 in Pharmaceutical Company Product News

Sanofi-aventis has revealed plans to collaborate with Regeneron to expand their joint portfolio of antibody products.

The two organisations will cooperate to discover, develop and commercialise fully-human therapeutic monoclonal antibodies.

Sanofi-aventis will increase its annual funding from $100 million (59.7 million pounds) to $160 million as of next year.

Overall, the firms are aiming to submit an average of four to five antibodies for clinical trials annually.

Leonard Schleifer, president and chief executive officer of Regeneron, explained: "The expansion of our collaboration provides even greater resources over a longer time horizon and will boost our efforts to build a deep pipeline of new human antibody product candidates."

In other Sanofi-aventis news, the firm revealed last week that it had performed well during the third quarter of 2009, as its net sales reached 7,400 million euros (6.631 million pounds).

Other news stories from 16/11/2009

Read more in the Zenopa News Archive

How this news is generated

Nikki
Account Manager
for this opportunity

01494 818032
(Mon to Fri 0830 to 1800 hours)
nikki@zenopa.com

Latest News

Sanofi-aventis announces 2009 financial outcome

Sanofi-aventis to purchase Chattem

Sanofi-aventis enters into agreement with Alopexx

Sanofi-aventis reveals EU approval of Multaq

Sanofi-aventis embarks upon major anti-malaria study

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use